PNC Financial Services Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165 | Sell |
397
-450
| -53% | -$187 | ﹤0.01% | 4811 |
|
|
2025
Q1 | $528 | Buy |
847
+530
| +167% | +$330 | ﹤0.01% | 4636 |
|
|
2024
Q4 | $529 | Buy |
317
+186
| +142% | +$310 | ﹤0.01% | 4519 |
|
|
2024
Q3 | $238 | Hold |
131
| – | – | ﹤0.01% | 4664 |
|
|
2024
Q2 | $790 | Hold |
131
| – | – | ﹤0.01% | 4473 |
|
|
2024
Q1 | $1.46K | Hold |
131
| – | – | ﹤0.01% | 4278 |
|
|
2023
Q4 | $1.95K | Buy |
131
+31
| +31% | +$462 | ﹤0.01% | 4193 |
|
|
2023
Q3 | $480 | Sell |
100
-832
| -89% | -$3.99K | ﹤0.01% | 4465 |
|
|
2023
Q2 | $7K | Hold |
932
| – | – | ﹤0.01% | 4013 |
|
|
2023
Q1 | $4.21K | Buy |
932
+832
| +832% | +$3.76K | ﹤0.01% | 4093 |
|
|
2022
Q4 | $1.13K | Hold |
100
| – | – | ﹤0.01% | 4388 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 4280 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 4309 |
|
|
2022
Q1 | $2K | Sell |
100
-2,000
| -95% | -$40K | ﹤0.01% | 4166 |
|
|
2021
Q4 | $45K | Buy |
2,100
+2,000
| +2,000% | +$42.9K | ﹤0.01% | 3161 |
|
|
2021
Q3 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 3832 |
|